US Edition
Paradromics Implants Brain-Computer Interface Into First Human Patient
- On May 14, during epilepsy surgery at the University of Michigan, Paradromics implanted its Connexus device—a neural interface system—into a person for the first time.
- The procedure followed years of preclinical trials and leveraged the opportunity of neurosurgery with low marginal risk to test the device safely and record neural signals.
- Connexus is smaller than a dime, uses 420 electrodes embedded in brain tissue to record neuron-level activity, and translates signals into communication for patients with severe motor impairments.
- Paradromics revealed it has secured close to $100 million in funding and plans to conduct additional surgeries in 2025. CEO Matt Angle emphasized that their technology achieves superior signal quality by being positioned very close to individual neurons.
- This milestone advances Paradromics into a clinical-stage company with planned trials to study long-term safety and use, suggesting progress toward future treatments for paralysis, stroke, and ALS.
31 Articles
31 Articles
Biotechnological startup Paradromics, Inc., reported that it successfully implemented a temporary brain-computer interface (BCI) in a human brain.Read more]]>
Paradromics implants brain-computer interface into first human patient
Paradromics, a competitor of Neuralink, announced Monday it safely implanted a brain-computer interface into a human patient last month and recorded neural activity, before removing it 10 minutes later.
With the help of a revolutionary robot, deaf patients will succeed in hearing again. Two AP-HP hospitals have succeeded in inserting highly advanced implants thanks to this technology, both on an infant and on a woman. The machine allows a slow and very precise insertion, without damaging the auditory system, as explained in this report by TF1. - "I will hear again": a woman and a baby benefit from a world premiere in two hospitals in Paris (Hea…
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
